Upcoming Webinars
USP General Chapter <665>: Separating Fact from Fiction
Presented by Desmond G Hunt, Senior Principal Scientist at US Pharmacopeia, Dr. Samuel Kikandi, Deputy Director- Principal Engineer at Sanofi
20th May 2026
Roundtable Discussion: Sterility Testing Challenges and Opportunities for ATMPs
Presented by Dr David Roesti, PhD. Microbiology Expert/Senior Technical Steward Manufacturing Science and Technology at Novartis Pharma AG, Irving Ford, VP of Quality & Compliance at Made Scientific, Friedrich von Wintzingerode, Director, ADQC Microbiological Sciences at Roche-Genentech, Sophie Drinkwater, Associate Director in Microbiology at AstraZeneca, Brian Conti, Product & Commercial Leader at Rapid Micro Biosystems , Dr. Joseph Pierquin, Founder and CTO of Redberry, part of Lonza and Stephane Dubreux, Pharm.D. / MBA, Scientific Affairs Director for Pharma Quality Control at bioMérieux
27th May 2026
Designed for More Than Launch: Accelerating Biosimilar Manufacturing at Scale
Presented by Mark Schofield, Cytiva, Director Science
22nd June 2026
Assessing the Use of Solid-Phase Cytometry for Rapid Bioburden Testing
Presented by Sophie Drinkwater, Associate Director in Microbiology at AstraZeneca
01st July 2026
From Error‑Prone Manual Steps to Flexible, Automated, Audit‑Ready Workflows: Delivering Better Results, Faster at genOway
Presented by Albane Flocon, Bioinformatics developer at genOway, Christel Merrouche, Head of preclinical processes at genOway and Stéphane Pitout - Director of Professional Sales (SciY)
02nd July 2026
Are We There Yet? A Digital Maturity Model for Enabling Process Monitoring and Artificial Intelligence in Biologics Manufacturing.
Presented by Jack Prior, Head of Process Monitoring & Data/AI Strategy at Sanofi
16th September 2026
Future Path for E&L per ISO 10993‑18: A Look at Emerging Technical Specifications
Presented by Sandi Schaible, President and Founder of Bonded in Science, LLC
22nd September 2026
Analytical Assessment of Leachables in Biological Drug Products: FDA’s Approach to Reviewing Information and Representative Review Cases
Presented by Andrey Sarafanov, PhD., Principal Investigator at U.S. FDA, Center for Biologics Evaluation and Research, Sarah Brophy, Global Scientific Director, E&L Element Materials Technology
24th September 2026
Aseptic Manufacturing for mRNA, ADCs, and Novel Biologics
Presented by Francesco Cicirello, Senior Director, Global Quality Compliance – BioNTainer at BioNTech
29th September 2026
Managing Analytical Procedure Lifecycles: Resolving Longstanding Mass Spectrometry Challenges for Emerging Nitrosamine and NDSRI Impurities
Presented by Jinhui Zhang, Chemist at FDA/CDER
30th September 2026
Overcoming Bottlenecks in PAT Deployment: Bridging the Gap Between Lab & Manufacturing
Presented by Luc Nguyen, Global Head of Process Analytical Technologies (PAT) within MSAT at Sanofi, Ramila Peiris, Global Head of Process Data Management, Machine Learning, and AI Platform MSAT at Sanofi
14th October 2026
PAT Evolution and Implementation: Navigating Regulatory Guidelines, and Best Practices for Tool Selection and Validation
Presented by Presented by Dr. Farshid Mohammadparast, Process Analytical Technology (PAT) and Chemometrics Principal Investigator at USP
16th October 2026
